CHARLES RIVER LABORATORIES INTERNATIONAL INC

For the period ended Dec 30, 2023. Filed Feb 14, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 14, 2024

CRL$345.80-2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Income for fiscal years and

(in thousands, except per share amounts)

	Fiscal Year
	2023	2022	2021
Service revenue	$3,440,019	$3,216,904	$2,755,579
Product revenue	689,390	759,156	784,581
Total revenue	4,129,409	3,976,060	3,540,160
Costs and expenses:
Cost of services provided (excluding amortization of intangible assets)	2,295,983	2,143,318	1,837,487
Cost of products sold (excluding amortization of intangible assets)	330,870	370,091	368,035
Selling, general and administrative	747,855	665,098	619,919
Amortization of intangible assets	137,440	146,578	124,857
Operating income	617,261	650,975	589,862
Other income (expense):
Interest income	5,196	780	652
Interest expense	(136,710)	(59,291)	(73,910)
Other income (expense), net	95,537	30,523	(35,894)
Income before income taxes	581,284	622,987	480,710
Provision for income taxes	100,914	130,379	81,873
Net income	480,370	492,608	398,837
Less: Net income attributable to noncontrolling interests	5,746	6,382	7,855
Net income attributable to common shareholders	$474,624	$486,226	$390,982
Earnings per common share
Net income attributable to common shareholders:
Basic	$9.27	$9.57	$7.77
Diluted	$9.22	$9.48	$7.60
Weighted-average number of common shares outstanding:
Basic	51,227	50,812	50,293
Diluted	51,451	51,301	51,425
See Notes to Consolidated Financial Statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.